SOCS-3 is an insulin-induced negative regulator of insulin signaling - PubMed (original) (raw)
. 2000 May 26;275(21):15985-91.
doi: 10.1074/jbc.275.21.15985.
Affiliations
- PMID: 10821852
- DOI: 10.1074/jbc.275.21.15985
Free article
SOCS-3 is an insulin-induced negative regulator of insulin signaling
B Emanuelli et al. J Biol Chem. 2000.
Free article
Abstract
The SOCS proteins are induced by several cytokines and are involved in negative feedback loops. Here we demonstrate that in 3T3-L1 adipocytes, insulin, a hormone whose receptor does not belong to the cytokine receptor family, induces SOCS-3 expression but not CIS or SOCS-2. Using transfection of COS-7 cells, we show that insulin induction of SOCS-3 is enhanced upon Stat5B expression. Moreover, Stat5B from insulin-stimulated cells binds directly to a Stat element present in the SOCS-3 promoter. Once induced, SOCS-3 inhibits insulin activation of Stat5B without modifying the insulin receptor tyrosine kinase activity. Two pieces of evidence suggest that this negative regulation likely results from competition between SOCS-3 and Stat5B binding to the same insulin receptor motif. First, using a yeast two-hybrid system, we show that SOCS-3 binds to the insulin receptor at phosphotyrosine 960, which is precisely where Stat5B binds. Second, using confocal microscopy, we show that insulin induces translocation of SOCS-3 from an intracellular compartment to the cell membrane, leading to colocalization of SOCS-3 with the insulin receptor. This colocalization is dependent upon phosphorylation of insulin receptor tyrosine 960. Indeed, in cells expressing an insulin receptor mutant in which tyrosine 960 has been mutated to phenylalanine, insulin does not modify the cellular localization of SOCS-3. We have thus revealed an insulin target gene of which the expression is potentiated upon Stat5B activation. By inhibiting insulin-stimulated Stat5B, SOCS-3 appears to function as a negative regulator of insulin signaling.
Similar articles
- Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone.
Ram PA, Waxman DJ. Ram PA, et al. J Biol Chem. 2000 Dec 15;275(50):39487-96. doi: 10.1074/jbc.M004755200. J Biol Chem. 2000. PMID: 10991939 - SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling.
Ridderstråle M, Amstrup J, Hilton DJ, Billestrup N, Tornqvist H. Ridderstråle M, et al. Horm Metab Res. 2003 Mar;35(3):169-77. doi: 10.1055/s-2003-39077. Horm Metab Res. 2003. PMID: 12734778 - Insulin Induction of SOCS-2 and SOCS-3 mRNA expression in C2C12 Skeletal Muscle Cells Is Mediated by Stat5*.
Sadowski CL, Choi TS, Le M, Wheeler TT, Wang LH, Sadowski HB. Sadowski CL, et al. J Biol Chem. 2001 Jun 8;276(23):20703-10. doi: 10.1074/jbc.M101014200. Epub 2001 Mar 13. J Biol Chem. 2001. PMID: 11279166 - The suppressors of cytokine signaling (SOCS) proteins: important feedback inhibitors of cytokine action.
Nicola NA, Greenhalgh CJ. Nicola NA, et al. Exp Hematol. 2000 Oct;28(10):1105-12. doi: 10.1016/s0301-472x(00)00525-7. Exp Hematol. 2000. PMID: 11027828 Review. - Suppressors of cytokine signalling: SOCS.
Larsen L, Röpke C. Larsen L, et al. APMIS. 2002 Dec;110(12):833-44. doi: 10.1034/j.1600-0463.2002.1101201.x. APMIS. 2002. PMID: 12645661 Review.
Cited by
- Lutein dietary supplementation attenuates streptozotocin-induced testicular damage and oxidative stress in diabetic rats.
Fatani AJ, Al-Rejaie SS, Abuohashish HM, Al-Assaf A, Parmar MY, Ahmed MM. Fatani AJ, et al. BMC Complement Altern Med. 2015 Jun 30;15:204. doi: 10.1186/s12906-015-0693-5. BMC Complement Altern Med. 2015. PMID: 26122042 Free PMC article. - SOCS Proteins Participate in the Regulation of Innate Immune Response Caused by Viruses.
Huang S, Liu K, Cheng A, Wang M, Cui M, Huang J, Zhu D, Chen S, Liu M, Zhao X, Wu Y, Yang Q, Zhang S, Ou X, Mao S, Gao Q, Yu Y, Tian B, Liu Y, Zhang L, Yin Z, Jing B, Chen X, Jia R. Huang S, et al. Front Immunol. 2020 Sep 25;11:558341. doi: 10.3389/fimmu.2020.558341. eCollection 2020. Front Immunol. 2020. PMID: 33072096 Free PMC article. Review. - Increased PARylation impacts the DNA methylation process in type 2 diabetes mellitus.
Zampieri M, Bacalini MG, Barchetta I, Scalea S, Cimini FA, Bertoccini L, Tagliatesta S, De Matteis G, Zardo G, Cavallo MG, Reale A. Zampieri M, et al. Clin Epigenetics. 2021 May 17;13(1):114. doi: 10.1186/s13148-021-01099-1. Clin Epigenetics. 2021. PMID: 34001206 Free PMC article. - Requirement of JIP1-mediated c-Jun N-terminal kinase activation for obesity-induced insulin resistance.
Morel C, Standen CL, Jung DY, Gray S, Ong H, Flavell RA, Kim JK, Davis RJ. Morel C, et al. Mol Cell Biol. 2010 Oct;30(19):4616-25. doi: 10.1128/MCB.00585-10. Epub 2010 Aug 2. Mol Cell Biol. 2010. PMID: 20679483 Free PMC article. - Sp3 is involved in the regulation of SOCS3 gene expression.
Ehlting C, Häussinger D, Bode JG. Ehlting C, et al. Biochem J. 2005 May 1;387(Pt 3):737-45. doi: 10.1042/BJ20041101. Biochem J. 2005. PMID: 15554904 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous